<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04933188</url>
  </required_header>
  <id_info>
    <org_study_id>ACFO2020</org_study_id>
    <nct_id>NCT04933188</nct_id>
  </id_info>
  <brief_title>Early Detection of Myocardial Work Impairment in Obesity (EARLY-MYO-OBESITY)</brief_title>
  <official_title>Early Detection of Myocardial Work Impairment in Patients With Overweight and Obesity (EARLY-MYO-OBESITY)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective study intends to explore the change of cardiac structure and function in the&#xD;
      cohort of overweight or obesity patients, and determine the impact of clinical&#xD;
      characteristics on cardiac remodeling and mechanics.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obesity significantly increases the risk for heart failure. Early detection of preclinical&#xD;
      cardiac dysfunction in overweight or obesity and understanding its association with insulin&#xD;
      resistance are of great importance.Recently, a novel technique for myocardial work (MW)&#xD;
      assessment has been introduced to evaluate myocardial performance. To date, change of MW has&#xD;
      been described in several cardiac conditions including dilated cardiomyopathy, significant&#xD;
      coronary arterial diseases, and hypertrophic cardiomyopathy, which implies regional or global&#xD;
      myocardial dysfunction. In this study, we aimed to explore the alteration of MW in overweight&#xD;
      or obese adults and to determine whether insulin resistance or other clinical risk factors&#xD;
      may impact myocardial mechanics before impairment of systolic function.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>investigate the change of global myocardial work index (GWI) in overweight or obese patients</measure>
    <time_frame>within 24 hours of the recruitment</time_frame>
    <description>GWI derived from echocardiography will be assessed in overweight or obese patients and compare with lean controls</description>
  </primary_outcome>
  <primary_outcome>
    <measure>investigate the change of global constructive work (GCW) in overweight or obese patients</measure>
    <time_frame>within 24 hours of the recruitment</time_frame>
    <description>GCW will be assessed in overweight or obese patients and compare with lean controls</description>
  </primary_outcome>
  <primary_outcome>
    <measure>investigate the change of global waste work (GWW) in overweight or obese patients</measure>
    <time_frame>within 24 hours of the recruitment</time_frame>
    <description>GWW will be assessed in overweight or obese patients and compare with lean controls</description>
  </primary_outcome>
  <primary_outcome>
    <measure>investigate the change of global work efficiency (GWE) in overweight or obese patients</measure>
    <time_frame>within 24 hours of the recruitment</time_frame>
    <description>GWE will be assessed in overweight or obese patients and compare with lean controls</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Overweight and Obesity</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>Lean health controls with a BMI&lt;25kg/m2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>overweight</arm_group_label>
    <description>patients with a BMI of 25-30kg/m2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>obesity</arm_group_label>
    <description>patients with a BMI of over 30kg/m2</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Myocardial work was estimated from left ventricular pressure-strain loop derived from speckle tracking echocardiography and non-invasive brachial artery cuff pressure</intervention_name>
    <description>Baseline and follow-up examination of echocardiography is to be performed on study subjects.</description>
    <arm_group_label>control</arm_group_label>
    <arm_group_label>obesity</arm_group_label>
    <arm_group_label>overweight</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        overweight or obese subjects referred to the endocrinology inpatients of Renji Hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients were older than 18 without any cardiac symptoms.&#xD;
&#xD;
          -  The diagnosis of overweight was established when body mass index (BMI) of 25 to 30&#xD;
             kg/m2.&#xD;
&#xD;
          -  Obese was defined as a BMI of 30 kg/m2 or higher.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  diagnosis of type 2-Diabetes Mellitus according to the American Diabetes Association&#xD;
             criteria;&#xD;
&#xD;
          -  left ventricular ejection fraction&lt;50% on echocardiography;&#xD;
&#xD;
          -  arrythmia on electrocardiogram;&#xD;
&#xD;
          -  severe valvular stenosis or regurgitation;&#xD;
&#xD;
          -  history of coronary disease (defined as stenosis&gt;50%) or myocardial infarction;&#xD;
&#xD;
          -  stress induced wall motion abnormality on echocardiography, coronary artery stenosis&#xD;
             &gt;50% on coronary CT or angiography with Framingham risk score of &gt;10;&#xD;
&#xD;
          -  pacemaker or defibrillator implantation;&#xD;
&#xD;
          -  the presence of bundle branch block;&#xD;
&#xD;
          -  severe infection or renal dysfunction with an estimated glomerular filtration rate &lt;&#xD;
             60 ml/min/1.73 m2);&#xD;
&#xD;
          -  inadequate image quality on echocardiography.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Meng Jiang</last_name>
    <role>Study Director</role>
    <affiliation>Renji Hospital, Shanghai</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hang Zhao</last_name>
    <phone>+8613764477850</phone>
    <email>zara_hang@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Renji Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hang Zhao</last_name>
      <phone>+8613764477850</phone>
      <email>zara_hang@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 30, 2021</study_first_submitted>
  <study_first_submitted_qc>June 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2021</study_first_posted>
  <last_update_submitted>June 17, 2021</last_update_submitted>
  <last_update_submitted_qc>June 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

